Yamaguchi Ken-ichi, Kishimoto Mitsumasa, & Okada Masato. (2012). Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA). BMC.
Chicago Style (17th ed.) CitationYamaguchi Ken-ichi, Kishimoto Mitsumasa, and Okada Masato. Tocilizumab (TCZ) May Be an Effective Treatment for Poly-juvenile Idiopathic Arthritis (pJIA) as for Rheumatoid Arthritis (RA). BMC, 2012.
MLA (9th ed.) CitationYamaguchi Ken-ichi, et al. Tocilizumab (TCZ) May Be an Effective Treatment for Poly-juvenile Idiopathic Arthritis (pJIA) as for Rheumatoid Arthritis (RA). BMC, 2012.
Warning: These citations may not always be 100% accurate.